TripTone 50 mg Oral Tablet
RxNorm 211486
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 211486 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: TripTone 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Dimenhydrinate 50 mg Oral Tablet [TripTone]
(Atom ID: 12364750)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
DimenhyDRINATE 50 mg Oral Tablet [TripTone]
(Atom ID: 3729326)
PSNPrescribable
Prescribable Name (PSN):
TripTone 50 mg Oral Tablet
(Atom ID: 6370841)
SYPrescribable
Synonym (SY):
Triptone 50 mg Oral Tablet
(Atom ID: 1166328)
Patient Education
Dimenhydrinate
Dimenhydrinate is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. Dimenhydrinate is in a class of medications called antihistamines. It works by preventing problems with body balance.
[Learn More]
* Please review the disclaimer below.